#U.S. Cell Culture Market Size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr has been banned in Indonesia for providing people with access to pornographic content.
Text
Future of U.S. Cell Culture Market: Insights from Industry Experts
The U.S. cell culture market size is anticipated to reach USD 10.97 billion by 2030 and is projected to grow at a CAGR of 10.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by various factors, such as the growth of biosimilars and biologics, advancements in stem cell research, and the emergence of bio-manufacturing technologies that facilitate the development of cell-based vaccines.
The COVID-19 pandemic has resulted in an increased demand for reliable cell-based vaccine production technologies. Furthermore, it has led to a few notable scientific breakthroughs, particularly in the development and testing of vaccine technologies. In August 2021, Danaher announced the manufacturing expansion of Cytiva and Pall which assisted in the drug and vaccine development for COVID and enabled expansion in manufacturing of various modalities such as cell culture and gene therapy to meet the demands during the pandemic.
Cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells. This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention. The cell line features faster doubling times to reduce processing timelines, has enhanced transfection efficiencies, and enables increased titer production at a lower cost.
Gather more insights about the market drivers, restrains and growth of the U.S. Cell Culture Market
U.S. Cell Culture Market Report Highlights
• The consumables segment led the market with the largest revenue share of 58.0% in 2023 and are expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D expenditure by biotechnology & biopharmaceutical businesses to develop sophisticated biologics, such as monoclonal antibodies & vaccines
• Based on application, the biopharmaceutical production segment led the market with the largest revenue share of 31.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period. The technological advancements in antibody therapeutics, such as the development of bispecific antibodies, antibody fragments, and antibody derivatives, are anticipated to expand the market prospects for applications of cell culture
U.S. Cell Culture Market Segmentation
Grand View Research has segmented U.S. cell culture market based on product, and application:
U.S. Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)
• Consumables
o Sera
o Reagents
o Media
o Instruments
U.S. Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)
• Biopharmaceutical Production
o Monoclonal Antibodies
o Vaccines Production
o Other Therapeutic Proteins
• Drug Development
• Diagnostics
• Tissue Culture & Engineering
• Cell & Gene Therapy
• Toxicity Testing
• Other Applications
Order a free sample PDF of the U.S. Cell Culture Market Intelligence Study, published by Grand View Research.
#U.S. Cell Culture Market#U.S. Cell Culture Market Size#U.S. Cell Culture Market Share#U.S. Cell Culture Market Analysis#U.S. Cell Culture Market Growth
0 notes
Text
According to Nova One Advisor, the U.S. 3D cell culture market size was estimated at USD 565.90 million in 2023 and is projected to hit around USD 1,621.36 million by 2033, growing at a CAGR of 11.1% during the forecast period from 2024 to 2033.
0 notes
Text
Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
Text
Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
Text
Microplate Instrumentation And Supplies Market : Technology Advancements, Industry Insights, Trends And Forecast 2033
The microplate instrumentation and supplies global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Microplate Instrumentation And Supplies Market, 2024The microplate instrumentation and supplies global market report 2024
Market Size -
The microplate instrumentation and supplies market size has grown strongly in recent years. It will grow from $6.49 billion in 2023 to $6.96 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to expansion of biotech and pharmaceutical companies, increasing the need for drug discovery and development, increasing the need for high-throughput screening tools, increasing investment from government agencies, and rising automation. The microplate instrumentation and supplies market size is expected to see strong growth in the next few years. It will grow to $9.26 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the growing demand for point-of-care testing and diagnostics, investments in research and development (R&D), rising frequency of chronic diseases, growing emphasis on genetics, and rising demand for personalized medicine. Major trends in the forecast period include integration of artificial intelligence and machine learning, adoption of 3D cell cultures and organoids in research, integration of cloud computing and internet of things (IoT) in microplates, integration of robotics, and developments in drug discovery and life science.
Order your report now for swift delivery @
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Overview
Market Drivers -The rising demand for personalized medicine is anticipated to drive the growth of the microplate instrumentation and supplies market in the near future. Personalized medicine, or precision medicine, is an approach that tailors treatment and healthcare strategies to individual patients based on their unique genetic, environmental, and lifestyle factors. This demand is fueled by the growing incidence of chronic conditions, heightened consumer awareness and expectations, and cost-effectiveness. Microplate instrumentation and supplies are essential in personalized medicine as they enable precise, high-throughput testing and analysis of biological samples, which is crucial for customizing medical treatments based on each patient's distinct genetic, biomolecular, and cellular profiles. For instance, according to the Personalized Medicine Coalition Reports in February 2024, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. Therefore, the rising demand for personalized medicine is propelling the growth of the microplate instrumentation and supplies market.
Market Trends -
Major companies operating in the microplate instrumentation and supplies market are focused on developing innovative products, such as EDR technology-based microplate readers, to improve assay accuracy, increase throughput, and streamline laboratory workflows. EDR (Extended Dynamic Range) technology-based microplate readers are advanced instruments designed to enhance the range and sensitivity of detection in various assays, which is particularly useful in personalized medicine and other research applications. For instance, in February 2022, BMG LABTECH, a Germany-based company specializing in developing microplate readers, launched the new VANTAstar microplate reader. This product incorporates EDR technology, which allows for a dynamic range spanning over eight concentration decades in a single measurement. This feature simplifies the process by eliminating the need for manual gain adjustments, as each plate is automatically read with optimal sensitivity settings.
The microplate instrumentation and supplies market covered in this report is segmented –
1) By Product Type: Microplate Readers, Microplate Washers, Microplate Dispensers, Microplate Accessories, Other Accessories 2) By Sales Channel: Direct Sales, Indirect Sales 3) By End-User Industries: Pharmaceuticals, Food And Beverages, Chemicals And Polymer, Other End-User Industries
Get an inside scoop of the microplate instrumentation and supplies market, Request now for Sample Report @
Regional Insights -
North America was the largest region in the microplate instrumentation and supplies market in 2023. The regions covered in the microplate instrumentation and supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies -
Major companies in the market are Thermo Fisher Scientific Inc., Danaher Corporation, The Merck Group, Corning Incorporated, Agilent Technologies Inc., Lonza Group AG, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Eppendorf AG, Promega Corporation, Hamilton Company, Molecular Devices LLC, Analytik Jena AG, Biochrom Ltd., OriGene Technologies Inc., Berthold Technologies GmbH & Co. KG, BMG LABTECH GmbH, BrandTech Scientific Inc., Hudson Robotics Inc., Labnet International Inc.
Table of Contents
1. Executive Summary 2. Microplate Instrumentation And Supplies Market Report Structure 3. Microplate Instrumentation And Supplies Market Trends And Strategies 4. Microplate Instrumentation And Supplies Market – Macro Economic Scenario 5. Microplate Instrumentation And Supplies Market Size And Growth ….. 27. Microplate Instrumentation And Supplies Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
0 notes
Text
Mammalian Cell Culture Dominates Biologics CDMO Industry
The global biologics contract development and manufacturing organization market achieved revenue of USD 17.1 billion in 2024 and is expected to grow at a rate of 11.0% between 2024 and 2030, reaching USD 31.8 billion by the end of the forecast period. This expansion is largely driven by the increasing prevalence of chronic diseases, the growing trend of outsourcing R&D activities, collaborations between biologics CDMOs and businesses for new product launches, and the rising aging population.
In 2023, the drug substance segment led the market, generating USD 8,525.4 million. Factors such as the rise in biologics approvals, particularly from the FDA, robust clinical pipelines, and lower failure rates of biologic drugs are boosting the demand for drug substances. Additionally, the biologics industry’s growth is propelling the demand for processes, often outsourced to CDMOs by small and mid-sized pharmaceutical firms. Outsourced biologics development activities include assay development, toxicology studies, and the establishment of master cell banks.
The expanding biopharma sector is driving strong demand for biologics outsourcing services. Small and mid-sized biotech companies are increasingly relying on outsourcing due to limited capacities and R&D capabilities.
Meanwhile, large pharmaceutical companies are also outsourcing R&D activities to biologics CDMOs, which offer comprehensive solutions aimed at reducing R&D costs, mitigating risks, and allowing companies to focus on core competencies for greater efficiency. This trend suggests that the biologics outsourcing market will experience significant growth in the coming years.
In 2023, mammalian cell culture was the leading segment, accounting for around 56% of the market share. This dominance is attributed to the growing development of more complex biologics, such as antibody-drug conjugates and multi-specific antibodies.
Moreover, the increasing demand for biologics CDMOs from pharmaceutical companies is boosting growth in this segment. Major players like Samsung Biologics, Lonza, and WuXi Biologics are expected to expand their mammalian cell culture capacities by 30–40% over the next decade.
By 2030, the biologics CDMO market in North America is projected to reach USD 7,802.9 million in revenue. This growth is driven by factors such as the increasing aging population, the rising incidence of chronic and serious diseases, and growing R&D investments by pharmaceutical and biotech companies. For instance, the U.S. elderly population, aged 65 and above, increased from 50 million in 2018 to 55 million in 2021.
According to the CDC, chronic illnesses such as diabetes, cancer, and heart disease were the leading causes of death in the U.S., costing healthcare systems over USD 4 trillion in 2021. Furthermore, data from the Partnership to Fight Chronic Disease (PFCD) suggests that approximately 45% of the U.S. population has at least one chronic disease, with 165 million Americans expected to have multiple chronic conditions by 2025.
0 notes
Text
Cell Culture 2023 Industry – Challenges, Drivers, Outlook, Segmentation - Analysis to 2030
Cell Culture Industry Overview
The global cell culture market size was estimated at USD 16.59 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.32% from 2023 to 2030.
Its growth can be attributed to the rapid adoption of cell culture techniques to develop substrates for the safe production of viral vaccines, and the rising global demand for advanced therapy medicinal products. Furthermore, novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development & vaccine production are expected to drive the market growth over the forecast period. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools.
Gather more insights about the market drivers, restrains and growth of the Cell Culture Market
Numerous prominent pharmaceutical and biotechnology companies have been engaging in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for applications in vaccine production and drug testing during the pandemic. In addition, several emerging and established players undertook various initiatives to capitalize on the increased demand for cell culture products due to the COVID-19 pandemic.
For instance, in January 2021, Captivate Bio, based in Massachusetts, U.S., launched its portfolio of cell culture tools for accelerating research applications for COVID-19 and other emerging diseases. Furthermore, in August 2022, Thermo Fisher Scientific expanded its New York-based dry powder media manufacturing facility to support the global demand for media products required for manufacturing COVID-19 vaccines and other biologics. Such initiatives are likely to positively impact the market growth over the forecast period. Furthermore, cell culture technology has applications in the development of functional tissues and organs as it enables researchers to create artificial organs that can replace damaged or malfunctioning organs in patients.
The potential impact of artificial organs in improving the quality of life for patients with organ failure is substantial and can drive the demand for cell culture techniques. In addition, cell culture-based vaccine production has gained prominence in recent years due to several advantages, including improved safety and faster production timelines offered by such vaccines. As a result, cell culture technology is being widely used for the production of several U.S.-licensed vaccines, including those for polio, rotavirus, smallpox, rubella, hepatitis, and chickenpox. Similarly, cell-based flu vaccines have been approved for use in several European countries. Hence, with the growing healthcare awareness and rising demand for vaccines, the market is anticipated to witness rapid expansion in the near future.
Browse through Grand View Research's Biotechnology Industry Research Reports.
• The global recombinant DNA technology market size was valued at USD 728.9 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030.
• The global DNA diagnostics market size was estimated at USD 10.64 billion in 2023 and is projected to grow at a CAGR of 4.51% from 2024 to 2030.
Global Cell Culture Market Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the cell culture marketreport on the basis of product, application, and region:
Product Scope Outlook (Revenue, USD Million, 2018 - 2030)
Consumables
Sera
Fetal Bovine Serum
Other
Reagents
Albumin
Others
Media
Serum-free Media
CHO Media
HEK 293 Media
BHK Medium
Vero Medium
Other Serum-free Media
Classical Media
Stem Cell Culture Media
Chemically Defined Media
Specialty Media
Other Cell Culture Media
Instruments
Culture Systems
Incubators
Centrifuges
Cryostorage Equipment
Biosafety Equipment
Pipetting Instruments
Application Outlook (Revenue, USD Million, 2018 - 2030)
Biopharmaceutical Production
Monoclonal Antibodies
Vaccines Production
Other Therapeutic Proteins
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell & Gene Therapy
Toxicity Testing
Other Applications
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Key Companies & Market Share Insights
Key market players are undertaking strategic initiatives, such as mergers & acquisitions, expansions, and new product developments, to extend their product portfolio and strengthen their market presence. For instance, in July 2023, Merck invested around USD 25.85 million (€23 million), in Kansas, the U.S., to increase the production of cell culture media. Some of the prominent players in the global cell culture market include:
Sartorius AG
Danaher
Merck KGaA
Thermo Fisher Scientific, Inc.
Corning Inc.
Avantor, Inc.
BD
Eppendorf SE
Bio-Techne
PromoCell GmbH
Order a free sample PDF of the Cell Culture Market Intelligence Study, published by Grand View Research.
0 notes
Text
Bioreactors Market - Forecast(2024 - 2030)
Bioreactors Market Overview
Bioreactors Market size is estimated to reach 2.1Bn, growing at a CAGR of 6.91% during the forecast period 2020-2025. Bioreactors are devices used to develop biological processes by closely monitoring controlled environment. It is a closed system used for bioprocessing, that supports the growth of cells or tissues and organisms (yeast, bacteria, or animal cells) under controlled conditions. Bioreactors are used in industrial processes to produce vaccines, antibodies and others. It converts raw materials into useful byproducts in the bioconversion of corn into ethanol. These are commonly cylindrical, ranging in size from liters to cubic meters, and are often made of stainless steel. Single-use material is widely used in the field of mammalian cell culture and is now rapidly replacing conventional bioreactors owing towards increase the quality of the end product by reducing automation complexity.
Report Coverage
The report: “Bioreactors Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Bioreactors Market.
By Type: Continuous Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fluidized Bed Bioreactors, Packed Bed Bioreactors and Photo-Bioreactors.
By Control Type: Manual Control and Automated Control.
By Application: Lab-Scale Production, Pilot-Scale Production and Full-Scale Production.
By Material: Glass, Stainless Steel and Single-Use Plastic Polymer.
By End User: Research & Development, Biopharmaceutics and Others.
By Geography: North America, Europe, Asia-Pacific and Rest of the World.
Request Sample
Key Takeaways
The increase in the number of personalized medicines coupled with rising number of FDA approved orphan drugs has increased bio production, accelerating the bioreactors demand over the forecast years.
Rising chronic diseases and favorable government initiatives to improve healthcare infrastructure is likely to be the major driving factor for the market’s growth.
Asia-Pacific region is projected to record the fastest growth rate during the forecast period 2020-2025
By Type - Segment Analysis
In 2019, Continuous Stirred Tank Bioreactors segment dominated the Bioreactors Market in terms of revenue is estimated to grow at a CAGR of 5.91% owing towards rising production of monoclonal antibodies (MAb) therapeutics and other biological using animal cell cultures. The continuous stirred-tank reactors are the equipped with an impeller for homogenizing culture media and a sparger for delivering oxygen to the cells. It has increased surface area for oxygen transfer, so there is an increased yield of products. These are mostly used in processing of industries, in homogeneous liquid-phase flow reactions, where constant agitation is required and which further is used in pharmaceutical industries abetting towards the growth of the market.
Inquiry Before Buying
Geography - Segment Analysis
In 2019, the North America region dominated Bioreactors Market in terms of revenue with a market share of 41.8% owing towards rising public & private funding for R&D in this region. In U.S., National Institute of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers with total investment of $215m aids to the market’s growth. Government has taken initiatives to promote technological advancements and initiatives to escalate the drug development process are key factors in the growth of the Bioreactors market. Asia Pacific is set to record the fastest growth rate during the forecast period 2020-2025.
Schedule a Call
Drivers – Bioreactors Market
Rapid Growth Of Single Use Bioreactors In Biopharmaceutical Industries
The increasing adoption of single use bioreactors by biopharmaceutical companies and various research institutions is driving the growth of the market. Single use bioreactors are more feasible than traditional bioreactors for small-scale research and lab-scale applications as they are more economical and flexible. The use of SUBs for the production of biopharmaceutical companies are increasing, as it tends to be more cost-effective for small-scale operations are driving the markets growth.
Challenges – Bioreactors Market
Major Regulatory Concerns
Regulatory concerns regarding usage of bioreactors and growing stringent government policy and regulation toward market growth is restraining growth of the market. Lack of sufficient storage facilities, vulnerability to leaching and transportation is hindering the market’s growth. Also, large-scale disposal of plastic derivatives is a growing environmental concern restraining the business growth over the forecast years.
Buy Now
Bioreactors Industry Outlook
Product Launches was the key strategy of the players in the Bioreactors Industry. Bioreactors top 10 companies include Danaher Corporation, Sartorius AG, Eppendorf AG, ZETA Holding GmbH, Applikon Biotechnology B.V., Solaris Biotechnology srl, Pierre Guerin Technologies, Thermo Fisher Scientific Inc., Finesse Solutions, Inc. and Merck KGaA.
Acquisitions/Product Launches
In May 2019, Sartorius AG, a leading international partner of the biopharmaceutical industry launched ambr® 15 cell culture automated microbioreactor system. It offers increased flexibility and expanded capability for clone selection, media and feed optimization and early process development work.
In March 2020, Thermo Fisher Scientific Inc. to acquire QIAGEN, a leading provider of life science and molecular diagnostic solutions. This acquisition provided opportunity to leverage the industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs.
In March 2020, Danaher Corporation acquired Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. This acquisition helped company by driving its growth across multiple categories and in reaching more consumers.
#Bioreactors Market#Bioreactors Market Share#Bioreactors Market Size#Bioreactors Market Forecast#Bioreactors Market Report#Bioreactors Market Growth
0 notes
Text
Meticulous Research® Unveils Comprehensive Report on Biopharmaceutical Processing Equipment and Consumables Market
August 7, 2024 - Meticulous Research®, a premier global market research firm, has released an in-depth report titled "Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031."
According to the latest findings by Meticulous Research, the global biopharmaceutical processing equipment and consumables market is projected to grow at a CAGR of 9.5%, reaching an estimated $83.39 billion by 2031. Key factors driving this market expansion include initiatives promoting biopharmaceutical adoption, capacity expansions in biopharmaceutical manufacturing plants, and the increasing use of single-use technologies in commercial bioproduction.
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Key Market Players
Prominent players in the global biopharmaceutical processing equipment and consumables market include:
3M Company (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher Corporation (U.S.)
Agilent Technologies, Inc. (U.S.)
Repligen Corporation (U.S.)
Sartorius AG (Germany)
Merck KGaA (Germany)
Eppendorf AG (Germany)
Solaris Biotechnology Srl (Italy)
Market Segmentation and Future Outlook
The global biopharmaceutical processing equipment and consumables market is segmented by product type, application, and end user:
Product Type: Filtration Systems, Chromatography Equipment and Consumables, Bioreactors, Cell Culture Products, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, and Other Consumables and Accessories.
Application: Commercial Bioproduction (including Vaccine Manufacturing, mAb Production, Recombinant Protein Production, and Cell and Gene Therapy Production) and Research Bioproduction.
End User: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), and Academic and Research Institutes.
Quick Buy: https://www.meticulousresearch.com/Checkout/87973509
Key Findings
Filtration Systems: In 2024, filtration systems are expected to dominate the market, holding a 22.3% share. This is attributed to the recurring use of filtration at every production step, technological advancements, and the growing need for single-use bioprocessing systems.
Commercial Bioproduction: This segment is anticipated to hold a 77.5% share in 2024, driven by the increasing number of biopharmaceuticals in clinical development and the rising demand for monoclonal antibodies to treat chronic diseases such as cancer, autoimmune diseases, and diabetes.
End Users: Pharmaceutical and biopharmaceutical companies are expected to dominate the market due to the high demand for biological products, favorable research initiatives, and high volumes of biopharmaceutical production globally.
Geographic Insights
The report provides a detailed geographic analysis, covering North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Europe is projected to lead the market in 2024 with a 33.2% share, with Germany being the largest market within the region, driven by substantial pharmaceutical exports, government grants, and expanding capacities for biologics-based drugs.
Access Request Sample Report : https://www.meticulousresearch.com/request-sample-report/cp_id=4200
Key Questions Addressed
Which are the high-growth market segments by product type, application, end user, and regions/countries?
What were the historical market trends for biopharmaceutical processing equipment and consumables globally?
What are the market forecasts and estimates for 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the market?
Who are the major players and what is the competitive landscape?
What recent developments have occurred in the market?
What strategies are adopted by key players?
What are the geographical trends and high-growth regions/countries?
Contact Us
Meticulous Research® Email: [email protected] Contact Sales: +1-646-781-8004 Connect with us on LinkedInMeticulous Research® Unveils Comprehensive Report on Biopharmaceutical Processing Equipment and Consumables Market
0 notes
Text
High Purity Solvents Market Analysis, Key Stakeholders, Regional Outlook, End-User Applicants by 2030
Global high purity solvents market generated revenue of US$ 36,542.0 million in 2021 and is estimated to reach valuation of US$ 64,003.7 million by 2030 at a CAGR of 6.5% during the forecast period, 2022–2030. By volume, the market is expected to reach 59,621.7 000’ MT in 2030 thus, growing with a CAGR of 5.2%.
Astute Analytica recently published a highly anticipated market report, providing invaluable insights into the Global High Purity Solvents Market. This comprehensive report offers a detailed analysis of key drivers, restraints, regional trends, segmentation, and valuation, enabling businesses to make informed decisions for sustainable growth.
A Request of this Sample PDF File@- https://www.astuteanalytica.com/request-sample/high-purity-solvents-market
Key Highlights of the Report:
Comprehensive Analysis: The report presents a holistic view of the High Purity Solvents Market, analyzing various factors such as market size, trends, and growth opportunities. This analysis helps businesses identify emerging market trends and make strategic decisions to drive growth.
Key Drivers and Restraints: The market report provides an in-depth analysis of the key drivers and restraints shaping the market. By understanding these factors, businesses can capitalize on growth opportunities and mitigate potential risks.
Valuation and Forecast: The report includes a thorough valuation of the market, providing businesses with a clear understanding of the market's current and future potential. This information assists in making well-informed investment decisions and strategic planning.
Regional Analysis: The report offers a detailed regional analysis, highlighting key market trends and opportunities across different geographic regions. This invaluable insight enables businesses to identify untapped markets and tailor their strategies accordingly.
Companies Profile
The report identifies and analyzes the key players in the High Purity Solvents Market. By understanding the competitive landscape, businesses can benchmark their performance and develop effective strategies to stay ahead.
Akzo Nobel N.V.
American International Chemical LLC
Apchem Pvt. Ltd.
Asahi Kasei Corporation
BASF SE
CABB Group GmbH
Central Drug House
Chemtronics
DAWN SCIENTIFIC INC
Dow
Evonik Industries AG
Exxon Mobil Corporation
FINAR
High Purity Laboratory Chemicals Pvt. Ltd.
Merck KGaA
Mitsubishi Chemical Corporation
Mountain Air
Spectrum Chemical Manufacturing Corp.
Thermo Fisher Scientific Inc.
Other Prominent Players
For Purchase Enquiry: https://www.astuteanalytica.com/industry-report/high-purity-solvents-market
Segmentation Overview:
The High Purity Solvents Market report provides a comprehensive segmentation overview, allowing businesses to identify and target specific customer segments. This segmentation analysis helps businesses customize their offerings and enhance their market presence.
By Type
Acetone
Ethanol
Heptane
Hexane
Isopropyl Alcohol
Methanol
Pentane
By Grade
HPLC Solvents
HPLC Isocratic Solvents
HPLC Gradient Solvents
HPLC Plus Solvents
LC-MS Solvents
UHPLC-MS Solvents
By Category
Polar Solvent
Non-polar Solvent
By Packaging
Amber bottles
Aluminum bottles
Recyclers
Borosilicate bottles
By End User
Laboratories
Culturing Cells and Tissues in Petri Dishes
Liquid Chromatography Analysis
Gas Chromatography Analysis
Molecular Biology Experiments
ICP-MS
Plastics & Adhesives
Sealants
Textiles
Pharmaceuticals
Food & Beverages
Chemicals
Cosmetics & Personal Care
Agriculture
Paints & Coatings
Soaps & Detergents
Electronics
Others
By Distribution Channel
Online
Offline
Direct
Distributor
By Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of MEA
South America
Argentina
Brazil
Rest of South America
The company has partnered with industry-leading experts, utilizing cutting-edge research methodologies and data analysis techniques to provide a reliable and accurate market report. With a focus on delivering actionable insights, this report is an indispensable tool for businesses looking to navigate the complexities of the High Purity Solvents Market and unlock new growth opportunities.
Download Sample PDF Report@- https://www.astuteanalytica.com/request-sample/high-purity-solvents-market
About Astute Analytica:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
Get in touch with us
Phone number: +18884296757
Email: [email protected]
Visit our website: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook | Pinterest
0 notes
Text
Influenza Diagnostics Market Insights: A Forecast Analysis for 2031 and Beyond
Influenza Diagnostics Market Overview
Straits Research, a leading market research and intelligence company in India, has published the latest report on the “Influenza Diagnostics Market” where you will find all the in-depth information regarding the industry.
The global influenza diagnostics market size was valued at USD 645.31 million in 2019 and is expected to grow at 7.7% CAGR during the forecast study period.
The Global Influenza Diagnostics Market report published by Straits Research analyses the growth potential of the said industry across various industrial segments. It brings forth a detailed study of the influencing factors of the market that includes the growth drivers, restraints, opportunities, challenges and the recent developments of the major key players in the said industry along with an estimated CAGR for the global Influenza Diagnostics market.
Competitive Analysis –
The “Influenza Diagnostics Market” report published offers a detailed in-depth analysis of the competitors operating in the industry with every inch of detail like history, financial and organizational growth, recent updates till the date the report is being published, etc. along with the forecasts of respective competitors.
Get a Free Sample Report of the Global Influenza Diagnostics Market @ https://straitsresearch.com/report/influenza-diagnostics-market/request-sample
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic, Becton
Dickinson and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience
GenMark Diagnostics
SA Scientific
Sekisui Diagnostics
bioMérieux SA
Danaher Corporation
Siemens Healthineers
Altona Diagnostics
CorisBioConcept
Are you concerned about the genuineness of the report? No need to worry! Get a FREE sample of our market reports and develop trust within our reports.
Research Methodology:
The global Influenza Diagnostics market report is prepared with an in-depth research process by following stringent guidelines and methodologies to offer you an accurate forecast for revenue generation and growth rate.
The overall market study is done through the data mining process by analyzing the revenues of the key vendors through sources like websites, annual reports, press releases, white papers, and government publishing sources.
Market Segmentation:
By Test Type
Traditional Diagnostic Test
RIDT
Cell Culture
DFA
Serological Assays
Molecular Diagnostic Test
RT-PCR
INNAT
TMA
LAMP
NASBA
Other INNAT
Other Molecular Tests
By Influenza Type
Influenza A
Influenza B
By End-User
Hospital
Point-of-Care Testing
Diagnostic Centers
Others
The Global Influenza Diagnostics Market Report forecasts the revenue growth with respect to significant geographies like -
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy)
Asia-Pacific (China, India, Japan, Singapore, Malaysia)
Middle-East & Africa
Latin America (Brazil, Mexico)
For example, in the Influenza Diagnostics Market, the North American region has its dominance over the global market, which is explained in detail with the requisite figures in this report. Thus the report offers an in-depth analysis of the latest industry trends and developments in each of the segments and sub-segments for the forecasted period of 2023-2031. The report also studies various sub-segments and classifications of the Global Influenza Diagnostics Market.
Buy Now: https://straitsresearch.com/buy-now/influenza-diagnostics-market
Key Findings of the Report:
The Global Influenza Diagnostics market report studies the market thoroughly and provides an approximate forecast for 2023-2031.
The said report includes an in-depth analysis of the latest developments in the Global Influenza Diagnostics market.
The report provides an easy-to-understand market definition and a list of leading players with their strategies to determine the market's competitive outlook.
The report also studies the drivers, restraints, opportunities, and challenges for the global Influenza Diagnostics market.
The Influenza Diagnostics market report provides historical data and forecasts revenue of the market segments and sub-segments for the main geographies including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The market for Influenza Diagnostics is partially consolidated and competitive, with the presence of leading players that contribute to the overall growth of the Influenza Diagnostics market.
Other features of the report:
The report analyzes key strategies focusing on the corporate structure, R&D methods, localization strategies, production capabilities, sales, and performance in various companies.
It provides valuable insights into the product portfolio, including product planning, development, and positioning in the global market.
The said report thoroughly studies the role of key players in the global Influenza Diagnostics market, along with their business developments and collaborations.
Latest Related Reports
https://www.wowonder.xyz/read-blog/38187
https://educatorpages.com/site/businessoutlook/pages/intracranial-pressure-monitoring-devices-market-challenges-to-2031
With all this detailed information specified related to the Global Influenza Diagnostics market, you might be interested to know more about the said market segment, for which you need to get the detailed research report of the Global Influenza Diagnostics Market published by Straits Research.
For that, you just need to click on the link below, do the transaction and get the report delivered to your mail-id.
It's as Simple as That!
Click here to buy the Global Influenza Diagnostics Market Report by Straits Research.
0 notes
Text
Gallium Nitride Device Market: Market Size and Forecast
The global gallium nitride (GaN) devices market reached USD 20.56 billion in 2019 and is anticipated to expand, rising from USD 21.18 billion in 2020 to USD 28.40 billion by 2027. This growth is expected to occur at a compound annual growth rate (CAGR) of 4.28% during the period spanning 2023 to 2027.
COVID-19: Increasing Sales of Smartphones and Laptops to Affect Growth
The COVID-19 pandemic is set to positively affect growth. Governments of various countries have implemented stringent lockdown measures to curb the spread of coronavirus. Owing to the work from culture, nowadays people are investing more in smartphones, IoT-based devices, laptops, and chargers. These factors are expected to surge the sales of these devices throughout 2020. We are also delivering accurate research reports to help you battle this pandemic and regain business confidence.
Browse In-depth Summary of This Research Insight:
Drivers & Restraints-
Expansion of Telecommunications Domain to Accelerate Growth
The demand for energy-efficient GaN devices is surging rapidly owing to the expansion of the telecommunications domain. Most of the internet service providers are nowadays focusing on providing lower latency with optical cable wires, ubiquitous connectivity, and network with higher capacity. Apart from that, the rising utilization of GaN devices in the 5G infrastructure is likely to propel the gallium nitride device market growth in the near future. However, the high cost associated with the maintenance and development of gallium nitride devices may hinder growth.
Segment-
Opto-semiconductor Device Segment to Grow Rapidly Backed by Increasing Usage in Lasers
Based on device type, the opto-semiconductor device segment procured the highest gallium nitride market share in 2019. This growth is attributable to their increasing usage in various aerospace applications, such as Light Detection and Ranging (LiDAR) and pulsed lasers. Besides, they are used in optoelectronics, LEDs, lasers, photodiodes, and solar cells.
Regional Insights-
High Demand for Wireless Devices to Favor Growth in Europe
Geographically, North America generated USD 7.38 billion in 2019 because of the presence of numerous prominent manufacturers, such as MACOM, Cree, Inc., Northrop Grumman Corporation, Efficient Power Conversion Corporation, Microsemi, and others in this region.
Europe, on the other hand, is anticipated to grow significantly on account of the rising demand for wireless devices in Germany, France, and the U.K. In Asia Pacific, the rising demand for gallium nitride devices from emerging nations, such as India and China would aid growth.
Competitive Landscape-
Key Companies Focus on Winning New Contracts to Intensify Competition
The global market for gallium nitride devices is highly fragmented with the presence of numerous reputed manufacturers. Most of them are focusing on achieving new contracts from significant governments, as well as private agencies to deliver their in-house products. Below are the two latest industry developments:
June 2020: Raytheon Missiles & Defense provided a contract worth USD 2.3 billion to the U.S. Missile Defense Agency (MDA). The latter will deliver seven GaN-based Army Navy/Transportable Radar Surveillance (AN/TPY-2) units. It is a part of the company’s Terminal High Altitude Area Defense (THAAD) system.
July 2019: Transphorm announced a new contract worth USD 18.5 million from the U.S. Department of Defense (DoD) Office of Naval Research (ONR). It includes a Base Program that is aimed at commercializing nitrogen polar GaN.
0 notes
Text
North America Bacteriophages Therapy Market Demands, Analysis, Size, Trends, Revenue by 2029
North America Bacteriophages Therapy Market, By Target (Escherichia Coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, Others), Type (Lytic, Lysogenic), Base (Sterile Broth Culture, Water-Soluble Jelly Base), Application (Bacterial Dysentery, Infections Of Skin And Nasal Mucosa, Suppurative Skin Infection, Lung And Pleural Infections, Postoperative Wound Infections, Others), Route Of Administration (Oral, Parenteral, Rectal, Dermal, Others), End-User (Hospitals, Speciality Clinics, Academic Research And Institutes, Others), Distribution Channel (Direct Tender, Third Party Distributors), Country (Germany, U.K., France, Italy, Georgia, Netherlands, Russia, Switzerland, Belgium, Turkey, Poland, Rest of Europe) Industry Trends and Forecast to 2028.
In the consistent North America Bacteriophages Therapy market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about North America Bacteriophages Therapy industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential North America Bacteriophages Therapy market report brings precise and exact market research information that drives business into the right direction.
Key Players
Aesculap, Inc. (U.S.)
Braun Melsungen AG (Germany)
Corin Group (U.K.)
Medical Devices Business Services, Inc. (U.S.)
Smith+ Nephew (U.K.)
Stryker (U.S.)
Zimmer Biomet (U.S.)
Exactech, Inc. (U.S.)
Medacta International (U.S.)
MicroPort Orthopedics Inc. (Switzerland)
Medtronic (U.S.)
Browse More Info @ https://www.databridgemarketresearch.com/reports/asia-pacific-bacteriophages-therapy-market
The research studies entailed in the winning North America Bacteriophages Therapy market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the North America Bacteriophages Therapy Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Market
Part 04: Global Market Size
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
More Reports:
Diuretic Drugs Market
Patient Engagement Technology Market
Healthcare Business Intelligence Market
Chinese Hamster Ovary cells (CHO) Market
Anti-cancer Drug Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
0 notes
Text
Mycoplasma Testing Market Likely To Reach Beyond $2.26 Billion By 2030
The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.4% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.
Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.
The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.
Increasing investments in R&D have contributed significantly to the market’s revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period
Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.
Request a free sample copy or view report summary: Mycoplasma Testing Market Report
Mycoplasma Testing Market Report Highlights
By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
By technology, the polymerase chain reaction segment held a largest share of 32.38% in 2022 which can be attributed to the technology's ability to give quick and precise findings
Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
By application, the cell line testing segment held a largest share of 41.46% in 2022, owing to the increase in research projects being done in the field of cell culture
Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
North America held the largest share of 39.08% in 2022. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
In Asia Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others
Mycoplasma Testing Market Segmentation
Grand View Research has segmented the global mycoplasma testing market on the basis of product, technology, application, end-use, and region:
Mycoplasma Testing Product Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Kits & Reagents
PCR Assays
Nucleic Acid Detection Kits
Stains
Elimination Kits
Standards & Controls
Others
Services
Mycoplasma Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
PCR
ELISA
Direct Assay
Indirect Assay
Microbial Culture Techniques
Enzymatic Methods
Mycoplasma Testing Application Outlook (Revenue, USD Million, 2018 - 2030)
Cell Line Testing
Virus Testing
End of Production Cells Testing
Others
Mycoplasma Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Research Institutes
Cell Banks
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Others
Mycoplasma Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
Spain
France
Italy
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Thailand
Australia
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Mycoplasma Testing Market
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza Group AG
Charles River Laboratories International, Inc.
PromoCell GmbH
American Type Culture Collection
Asahi Kasei Medical Co., Ltd.
Sartorius AG
InvivoGen
Eurofins Scientific
0 notes
Text
Biopharmaceutical CMO & CRO Production Capacity Study—a Deep-dive on Firms Opting for Contract Services
CMOs are exploring the potential of mammalian cell culture production amidst soaring demand for biopharmaceutical contract manufacturing services. Incumbents, such as Charles River and Lonza have furthered investments in mammalian cells. To illustrate, in May 2021, Lonza announced pouring USD 936 million to bolster the footprint of mammalian drug substance manufacturing sites in the U.S. and Switzerland.
Biopharmaceutical firms are responding to the demand for outsourced services with bullish investments in research activities. For instance, in July 2022, Wuxi Biologics contemplated expanding its large-scale drug product & drug substance manufacturing capabilities and R&D in Singapore.
Adoption of Contract Development & Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) with surging demand for Monoclonal Antibodies (MAbs) products will boost the market share. The final report, along with the database, will peruse the following dynamics:
• Insights on commercial availability and annual approvals of MAb products.
• Commercially available biopharmaceuticals and biologics produced using mammalian cell lines.
• Competitive landscape with industry developments.
• CMO Mapping of 88 companies.
Get your copy or request a free sample of the report “Biopharmaceutical CMO & CRO Production Capacity Study,” compiled and published by Grand View Research.
Biopharmaceutical CMO & CRO Production Capacity Report Scope
CMO Capacity mapping (for 88 companies)
Key Players: Location Mapping & existing Capacities
Recent expansions/ Future plans
Comparative Heat Map
Get more insights from our in-depth market intelligence report, “Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2023 – 2030.”
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
#CRO Production Capacity Report#biopharmaceutical industry#Market Trend Reports#Biopharmaceutical CMO#Biopharmaceutical Firms#contract services
0 notes
Text
Meticulous Research® Unveils Comprehensive Report on Biopharmaceutical Processing Equipment and Consumables Market
August 7, 2024 - Meticulous Research®, a premier global market research firm, has released an in-depth report titled "Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031."
According to the latest findings by Meticulous Research, the global biopharmaceutical processing equipment and consumables market is projected to grow at a CAGR of 9.5%, reaching an estimated $83.39 billion by 2031. Key factors driving this market expansion include initiatives promoting biopharmaceutical adoption, capacity expansions in biopharmaceutical manufacturing plants, and the increasing use of single-use technologies in commercial bioproduction.
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Key Market Players
Prominent players in the global biopharmaceutical processing equipment and consumables market include:
3M Company (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher Corporation (U.S.)
Agilent Technologies, Inc. (U.S.)
Repligen Corporation (U.S.)
Sartorius AG (Germany)
Merck KGaA (Germany)
Eppendorf AG (Germany)
Solaris Biotechnology Srl (Italy)
Market Segmentation and Future Outlook
The global biopharmaceutical processing equipment and consumables market is segmented by product type, application, and end user:
Product Type: Filtration Systems, Chromatography Equipment and Consumables, Bioreactors, Cell Culture Products, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, and Other Consumables and Accessories.
Application: Commercial Bioproduction (including Vaccine Manufacturing, mAb Production, Recombinant Protein Production, and Cell and Gene Therapy Production) and Research Bioproduction.
End User: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), and Academic and Research Institutes.
Quick Buy: https://www.meticulousresearch.com/Checkout/87973509
Key Findings
Filtration Systems: In 2024, filtration systems are expected to dominate the market, holding a 22.3% share. This is attributed to the recurring use of filtration at every production step, technological advancements, and the growing need for single-use bioprocessing systems.
Commercial Bioproduction: This segment is anticipated to hold a 77.5% share in 2024, driven by the increasing number of biopharmaceuticals in clinical development and the rising demand for monoclonal antibodies to treat chronic diseases such as cancer, autoimmune diseases, and diabetes.
End Users: Pharmaceutical and biopharmaceutical companies are expected to dominate the market due to the high demand for biological products, favorable research initiatives, and high volumes of biopharmaceutical production globally.
Geographic Insights
The report provides a detailed geographic analysis, covering North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Europe is projected to lead the market in 2024 with a 33.2% share, with Germany being the largest market within the region, driven by substantial pharmaceutical exports, government grants, and expanding capacities for biologics-based drugs.
Access Request Sample Report : https://www.meticulousresearch.com/request-sample-report/cp_id=4200
Key Questions Addressed
Which are the high-growth market segments by product type, application, end user, and regions/countries?
What were the historical market trends for biopharmaceutical processing equipment and consumables globally?
What are the market forecasts and estimates for 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the market?
Who are the major players and what is the competitive landscape?
What recent developments have occurred in the market?
What strategies are adopted by key players?
What are the geographical trends and high-growth regions/countries?
Contact Us
Meticulous Research® Email: [email protected] Contact Sales: +1-646-781-8004 Connect with us on LinkedIn
0 notes